The exosomal lncRNA DOCK9-AS2 enhances EMT and stemness in PTC by modulating the Wnt/β-catenin pathway while interacting with SP1/miR-1972 signaling to support an aggressive tumor phenotype [26]. This evidence concerns the gene SP1 and neoplasm.